ArticleStem cell reviews and reports2026
FGF2 Enhances MSCs Secretome Therapy for Skin Photoaging by Delaying Senescence via iNAMPT/AMPK Signaling and Facilitating eNAMPT-Mediated Regenerative Crosstalk.
Article in Stem cell reviews and reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diversity and Predicted Impact of miRNAs in Human MSCs-derived Extracellular Vesicles.Stem cell reviews and reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Mesenchymal stem cells (MSCs) show great potential for combating aging-related tissue degeneration, yet their clinical translation is hampered by serum-dependent culture. Here, we report a GMP-compliant serum-free (SF) system for human umbilical cord MSCs (hUC-MSCs) and demonstrate that their secretome exerts superior efficacy against UVB-induced skin photoaging compared to serum-containing counterparts, such as increased dermal thickness, improved angiogenesis and upregulated levels of senescence-associated proteins. Further, this enhanced activity was investigated to correlate with elevated NAMPT. Crucially, FGF2, a predefined SF medium component, was identified as a NAMPT-mediated dual-functional modulator for both delaying MSCs senescence and enhancing the anti-photoaging effect of secretome. Mechanistically, we found that extracellular NAMPT directly counteract photoaging via extracellular vesicle delivery approach, while intracellular NAMPT regulated senescence-, proliferation-, and apoptosis-related genes through FGFR/NAMPT/AMPK signaling pathway, synergistically influencing on the anti-photoaging function of secretome. Our work proposes a cell-free secretome-based strategy for skin anti-photoaging and demonstrates the dual roles of FGF2 in enhancing cell viability and paracrine activity.
Indexed as
Identifiers
41326923What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.